Alimera Sciences Announces the Appointment of Industry Veteran and Ophthalmology Business Executive John Snisarenko to its Board of Directors

    NEXT STORY
    Generex Biotechnology Announces Satisfaction of Debt Obligation
    PREV STORY
    Global Biopharmaceuticals Market Overview, 2018-2019 & Forecast to 2025
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sublimity Therapeutics Appoints Jesse W. Hall as Chief Medical Officer

    DUBLIN, Ireland, July 30, 2018 (GLOBE NEWSWIRE) -- Sublimity Therapeutics, a specialty pharmaceutical company ...

    author_avatar
    NASDAQ Market News

    Merus’ Intellectual Property Portfolio Expands with Two New Patents

    UTRECHT, The Netherlands, March 13, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    Aduro Biotech Highlights Preclinical Data for Three Programs Reported at the American Association for Cancer Research Annual Meeting

    author_avatar
    NASDAQ Market News